Lunai Bioworks Inc.
NASDAQLNAI short interest plummets 31% in one week to 11.1% of float, as cost to borrow slides to 166.5% from 297%.
Lunai Bioworks heads into today's earnings print wrapped in one of the most aggressive short-selling setups in the small-cap biotech universe. Short interest has roughly doubled in the past month. It now runs at nearly…
Lunai Bioworks heads into tomorrow's Q3 earnings print with a genuinely charged setup: short interest has more than doubled in a week, borrowing costs remain historically extreme, and the company itself has gone to war…
Snapshot as of 22 Jun 2026
LNAI shorts have moved fast. Short interest jumped 211% in one week to 18.9% of float. Cost to borrow hit 290%. Earnings land in two days. Short shares outstanding stood at roughly 1.4 million on May 1. By May 8, that…
Lunai Bioworks reports Q3 2026 results on May 8 with a borrow market that, despite cooling sharply from its March extremes, remains far more expensive than most small-cap biotechs — and a short interest picture that…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for LNAI — free to start on ORTEX.
Sign up for free →Open LNAI on ORTEX